Linde Aktiengesellschaft

Linde Aktiengesellschaft is a major international industrial gases and engineering company based in Germany, operating globally in the production and distribution of specialized industrial, medical, and aviation gases. As a for-profit organization registered in the System for Award Management (SAM), Linde AG provides critical gas products to various U.S. federal government agencies, with a particular focus on supporting Department of Defense (DoD) operations and healthcare facilities. The company is a child entity within a larger corporate structure and has been registered to receive federal awards since September 29, 2004.

Through its federal contract awards, Linde AG has consistently supplied specialized gases to U.S. defense agencies, primarily the Defense Logistics Agency (DLA) Energy and the Department of the Army Medical Command. The company's primary goods include aviator's breathing oxygen, technical nitrogen, medical gases, and dry ice, which are delivered to military installations, air force bases, and medical treatment facilities across Europe and the United States. All of Linde AG's federal contract awards have been made without specific set-aside designations, indicating the company's competitive position as a commercial supplier. The contract awards have been predominantly focused on supporting military aviation operations, industrial processes, and healthcare services for U.S. forces stationed abroad, with delivery orders typically ranging from $1,000 to $3,500.

Linde Aktiengesellschaft currently holds a significant indefinite delivery contract (IDC) with the Defense Logistics Agency Energy, valued at $394,810, which covers the delivery of aviator's breathing oxygen and technical nitrogen to Department of Defense locations across Europe through November 2026. This contract, awarded on May 10, 2021, is a single-award IDC that allows Linde AG to provide critical gases to support military operations. Concurrently, the company maintains a separate $103,000 IDC with the Department of the Army Medical Command for delivering medical gases to military treatment facilities in Germany through September 2024. These IDVs demonstrate Linde AG's strategic importance in maintaining operational readiness and medical capabilities for U.S. forces stationed abroad by providing a consistent and reliable supply of essential gases through multiple task orders and delivery mechanisms.